These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37012169)

  • 1. Preclinical Research Highlighting Contemporary Targeting Mechanisms of Radiolabelled Compounds for PET Based Infection Imaging.
    Kleynhans J; Sathekge MM; Ebenhan T
    Semin Nucl Med; 2023 Sep; 53(5):630-643. PubMed ID: 37012169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Advancements in Radiopharmaceuticals for Infection Imaging.
    Dadachova E; Rangel DEN
    Methods Mol Biol; 2024; 2813():205-217. PubMed ID: 38888780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature.
    Evangelista L; Briganti A; Fanti S; Joniau S; Reske S; Schiavina R; Stief C; Thalmann GN; Picchio M
    Eur Urol; 2016 Jul; 70(1):161-175. PubMed ID: 26850970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and Preclinical Evaluation of Folate-NOTA-Al(18)F for PET Imaging of Folate-Receptor-Positive Tumors.
    Chen Q; Meng X; McQuade P; Rubins D; Lin SA; Zeng Z; Haley H; Miller P; González Trotter D; Low PS
    Mol Pharm; 2016 May; 13(5):1520-7. PubMed ID: 27054811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folate-PEG-NOTA-Al
    Chen Q; Meng X; McQuade P; Rubins D; Lin SA; Zeng Z; Haley H; Miller P; González Trotter D; Low PS
    Mol Pharm; 2017 Dec; 14(12):4353-4361. PubMed ID: 29028357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactor produced [
    Chakravarty R; Shetty P; Nair KVV; Rajeswari A; Jagadeesan KC; Sarma HD; Rangarajan V; Krishnatry R; Chakraborty S
    Ann Nucl Med; 2020 Dec; 34(12):899-910. PubMed ID: 33048309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recently developed radiopharmaceuticals for bacterial infection imaging.
    Kahts M; Summers B; Gutta A; Pilloy W; Ebenhan T
    EJNMMI Radiopharm Chem; 2024 Jun; 9(1):49. PubMed ID: 38896373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is the Best Radionuclide for Immuno-PET of Multiple Myeloma? A Comparison Study Between
    Bailly C; Gouard S; Guérard F; Chalopin B; Carlier T; Faivre-Chauvet A; Remaud-Le Saëc P; Bourgeois M; Chouin N; Rbah-Vidal L; Tripier R; Haddad F; Kraeber-Bodéré F; Bodet-Milin C; Chérel M
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular imaging of cancer with copper-64 radiopharmaceuticals and positron emission tomography (PET).
    Shokeen M; Anderson CJ
    Acc Chem Res; 2009 Jul; 42(7):832-41. PubMed ID: 19530674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A broad overview of positron emission tomography radiopharmaceuticals and clinical applications: what is new?
    Vallabhajosula S; Solnes L; Vallabhajosula B
    Semin Nucl Med; 2011 Jul; 41(4):246-64. PubMed ID: 21624560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
    Vallabhajosula S
    Semin Nucl Med; 2007 Nov; 37(6):400-19. PubMed ID: 17920348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A decade of ubiquicidin development for PET imaging of infection: A systematic review.
    Marjanovic-Painter B; Kleynhans J; Zeevaart JR; Rohwer E; Ebenhan T
    Nucl Med Biol; 2023; 116-117():108307. PubMed ID: 36435145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copper-64 based radiopharmaceuticals for brain tumors and hypoxia imaging.
    Pasquali M; Martini P; Shahi A; Jalilian AR; Osso JA; Boschi A
    Q J Nucl Med Mol Imaging; 2020 Dec; 64(4):371-381. PubMed ID: 33026209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3p-C-NETA: A versatile and effective chelator for development of Al
    Ahenkorah S; Murce E; Cawthorne C; Ketchemen JP; Deroose CM; Cardinaels T; Seimbille Y; Fonge H; Gsell W; Bormans G; Ooms M; Cleeren F
    Theranostics; 2022; 12(13):5971-5985. PubMed ID: 35966589
    [No Abstract]   [Full Text] [Related]  

  • 16. State of the Art in Radiolabeling of Antibodies with Common and Uncommon Radiometals for Preclinical and Clinical Immuno-PET.
    Chomet M; van Dongen GAMS; Vugts DJ
    Bioconjug Chem; 2021 Jul; 32(7):1315-1330. PubMed ID: 33974403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a Theranostic Convergence Bioradiopharmaceutical for Immuno-PET Based Radioimmunotherapy of L1CAM in Cholangiocarcinoma Model.
    Song IH; Jeong MS; Hong HJ; Shin JI; Park YS; Woo SK; Moon BS; Kim KI; Lee YJ; Kang JH; Lee TS
    Clin Cancer Res; 2019 Oct; 25(20):6148-6159. PubMed ID: 31337646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear medicine imaging of bone infections.
    Love C; Palestro CJ
    Clin Radiol; 2016 Jul; 71(7):632-46. PubMed ID: 26897336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positron emission tomography radiopharmaceuticals for imaging brain Beta-amyloid.
    Vallabhajosula S
    Semin Nucl Med; 2011 Jul; 41(4):283-99. PubMed ID: 21624562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unknown SARS-CoV-2 pneumonia detected by PET/CT in patients with cancer.
    Scarlattei M; Baldari G; Silva M; Bola S; Sammartano A; Migliari S; Graziani T; Cidda C; Sverzellati N; Ruffini L
    Tumori; 2020 Aug; 106(4):325-332. PubMed ID: 32567505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.